{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,11]],"date-time":"2026-02-11T13:30:54Z","timestamp":1770816654862,"version":"3.50.1"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,16]],"date-time":"2026-01-16T00:00:00Z","timestamp":1768521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,2,10]],"date-time":"2026-02-10T00:00:00Z","timestamp":1770681600000},"content-version":"vor","delay-in-days":25,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"DOI":"10.1186\/s12879-026-12557-7","type":"journal-article","created":{"date-parts":[[2026,1,16]],"date-time":"2026-01-16T17:25:44Z","timestamp":1768584344000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Bacterial distribution and disease burden analysis in hospital-acquired bloodstream infections according to Diagnosis-Related Groups (DRGs) data"],"prefix":"10.1186","volume":"26","author":[{"given":"Min","family":"Liu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richun","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhuobing","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ke","family":"He","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ling","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,1,16]]},"reference":[{"issue":"2","key":"12557_CR1","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1007\/s00134-020-05950-6","volume":"46","author":"JF Timsit","year":"2020","unstructured":"Timsit JF, Rupp\u00e9 E, Barbier F, Tabah A, Bassetti M. Bloodstream infections in critically ill patients: an expert statement. Intensive Care Med. 2020;46(2):266\u201384.","journal-title":"Intensive Care Med"},{"issue":"18","key":"12557_CR2","doi-asserted-by":"publisher","first-page":"5494","DOI":"10.7150\/jca.50802","volume":"12","author":"S Chen","year":"2021","unstructured":"Chen S, Lin K, Li Q, Luo X, Xiao M, Chen M, Zhu H, Chen Y, Wu X, Zeng Y, Zhang Y, Ally IH, Xu J, Ren J, Chen Z, Hu J, Yang T. A practical update on the epidemiology and risk factors for the emergence and mortality of bloodstream infections from real-world data of 3014 hematological malignancy patients receiving chemotherapy. J Cancer. 2021;12(18):5494\u2013505.","journal-title":"J Cancer"},{"issue":"2","key":"12557_CR3","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/j.jinf.2016.11.001","volume":"74","author":"C Adrie","year":"2017","unstructured":"Adrie C, Garrouste-Orgeas M, Ibn Essaied W, Schwebel C, Darmon M, Mourvillier B, Ruckly S, Dumenil AS, Kallel H, Argaud L, Marcotte G, Barbier F, Laurent V, Goldgran-Toledano D, Clec\u2019h C, Azoulay E, Souweine B, Timsit JF. OUTCOMEREA study Group*. Attributable mortality of ICU-acquired bloodstream infections: impact of the source, causative micro-organism, resistance profile and antimicrobial therapy. J Infect. 2017;74(2):131\u201341.","journal-title":"J Infect"},{"issue":"3","key":"12557_CR4","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1080\/21505594.2015.1132142","volume":"7","author":"D Yahav","year":"2016","unstructured":"Yahav D, Eliakim-Raz N, Leibovici L, Paul M. Bloodstream infections in older patients. Virulence. 2016;7(3):341\u201352.","journal-title":"Virulence"},{"issue":"5","key":"12557_CR5","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1017\/S0950268810001640","volume":"139","author":"MN Al-Hasan","year":"2011","unstructured":"Al-Hasan MN, Huskins WC, Lahr BD, Eckel-Passow JE, Baddour LM. Epidemiology and outcome of Gram-negative bloodstream infection in children: a population-based study. Epidemiol Infect. 2011;139(5):791\u20136.","journal-title":"Epidemiol Infect"},{"issue":"2","key":"12557_CR6","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1016\/S1473-3099(20)30477-1","volume":"21","author":"SS Kadri","year":"2021","unstructured":"Kadri SS, Lai YL, Warner S, Strich JR, Babiker A, Ricotta EE, Demirkale CY, Dekker JP, Palmore TN, Rhee C, Klompas M, Hooper DC, Powers JH 3rd, Srinivasan A, Danner RL, Adjemian J, forming the National Insititutes of Health Antimicrobial Resistance Outcomes Research Initiative (NIH-ARORI). Inappropriate empirical antibiotic therapy for bloodstream infections based on discordant in-vitro susceptibilities: a retrospective cohort analysis of prevalence, predictors, and mortality risk in US hospitals. Lancet Infect Dis. 2021;21(2):241\u201351.","journal-title":"Lancet Infect Dis"},{"issue":"5","key":"12557_CR7","doi-asserted-by":"publisher","first-page":"784","DOI":"10.1016\/j.jiph.2019.11.014","volume":"13","author":"H Chang","year":"2020","unstructured":"Chang H, Wei J, Zhou W, Yan X, Cao X, Zuo L, Chen S, Yao K, Huang R, Chen Y, Wu C. Risk factors and mortality for patients with bloodstream infections of Klebsiella pneumoniae during 2014\u20132018: clinical impact of carbapenem resistance in a large tertiary hospital of China. J Infect Public Health. 2020;13(5):784\u201390.","journal-title":"J Infect Public Health"},{"issue":"8","key":"12557_CR8","doi-asserted-by":"publisher","first-page":"3655","DOI":"10.1128\/JCM.41.8.3655-3660.2003","volume":"41","author":"DJ Diekema","year":"2003","unstructured":"Diekema DJ, Beekmann SE, Chapin KC, Morel KA, Munson E, Doern GV. Epidemiology and outcome of nosocomial and community-onset blood-stream infection. J Clin Microbiol. 2003;41(8):3655\u201360.","journal-title":"J Clin Microbiol"},{"issue":"1","key":"12557_CR9","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1186\/s12879-022-07267-9","volume":"22","author":"SJ Mun","year":"2022","unstructured":"Mun SJ, Kim SH, Kim HT, Moon C, Wi YM. The epidemiology of bloodstream infection contributing to mortality: the difference between community-acquired, healthcare-associated, and hospital-acquired infections. BMC Infect Dis. 2022;22(1):336.","journal-title":"BMC Infect Dis"},{"key":"12557_CR10","doi-asserted-by":"publisher","first-page":"102571","DOI":"10.1016\/j.eclinm.2024.102571","volume":"71","author":"H Melariri","year":"2024","unstructured":"Melariri H, Freercks R, van der Merwe E, Ham-Baloyi WT, Oyedele O, Murphy RA, Claasen C, Etusim PE, Achebe MO, Offiah S, Melariri PE. The burden of hospital-acquired infections (HAI) in sub-Saharan africa: a systematic review and meta-analysis. EClinicalMedicine. 2024;71:102571.","journal-title":"EClinicalMedicine"},{"issue":"3","key":"12557_CR11","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1086\/421946","volume":"39","author":"H Wisplinghoff","year":"2004","unstructured":"Wisplinghoff H, Bischoff T, Tallent SM, Seifert H, Wenzel RP, Edmond MB. Nosocomial bloodstream infections in US hospitals: analysis of 24,179 cases from a prospective nationwide surveillance study. Clin Infect Dis. 2004;39(3):309\u201317.","journal-title":"Clin Infect Dis"},{"issue":"12","key":"12557_CR12","doi-asserted-by":"publisher","first-page":"ofab552","DOI":"10.1093\/ofid\/ofab552","volume":"8","author":"N Petersiel","year":"2021","unstructured":"Petersiel N, Sherman A, Paul M. The impact of nosocomial bloodstream infections on mortality: A retrospective Propensity-Matched cohort study. Open Forum Infect Dis. 2021;8(12):ofab552.","journal-title":"Open Forum Infect Dis"},{"key":"12557_CR13","first-page":"Doc03","volume":"7","author":"M Wilke","year":"2019","unstructured":"Wilke M, Worf K, Preisend\u00f6rfer B, Heinlein W, Kast T, Bodmann KF. Potential savings through single-dose intravenous Dalbavancin in long-term MRSA infection treatment - a health economic analysis using German DRG data. GMS Infect Dis. 2019;7:Doc03.","journal-title":"GMS Infect Dis"},{"issue":"7","key":"12557_CR14","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1016\/j.healthpol.2018.04.013","volume":"122","author":"PL Annear","year":"2018","unstructured":"Annear PL, Kwon S, Lorenzoni L, Duckett S, Huntington D, Langenbrunner JC, Murakami Y, Shon C, Xu K. Pathways to DRG-based hospital payment systems in Japan, Korea, and Thailand. Health Policy. 2018;122(7):707\u201313.","journal-title":"Health Policy"},{"issue":"6","key":"12557_CR15","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1111\/1469-0691.12195","volume":"19","author":"M Goto","year":"2013","unstructured":"Goto M, Al-Hasan MN. Overall burden of bloodstream infection and nosocomial bloodstream infection in North America and Europe. Clin Microbiol Infect. 2013;19(6):501\u20139.","journal-title":"Clin Microbiol Infect"},{"key":"12557_CR16","doi-asserted-by":"publisher","first-page":"baae046","DOI":"10.1093\/database\/baae046","volume":"2024","author":"S Ren","year":"2024","unstructured":"Ren S, Yang L, Du J, He M, Shen B. DRGKB: a knowledgebase of worldwide diagnosis-related groups\u2019 practices for comparison, evaluation and knowledge-guided application. Database (Oxford). 2024;2024:baae046.","journal-title":"Database (Oxford)"},{"key":"12557_CR17","doi-asserted-by":"publisher","first-page":"f3197","DOI":"10.1136\/bmj.f3197","volume":"346","author":"R Busse","year":"2013","unstructured":"Busse R, Geissler A, Aaviksoo A, Cots F, H\u00e4kkinen U, Kobel C, Mateus C, Or Z, O\u2019Reilly J, Serd\u00e9n L, Street A, Tan SS, Quentin W. Diagnosis related groups in europe: moving towards transparency, efficiency, and quality in hospitals. BMJ. 2013;346:f3197.","journal-title":"BMJ"},{"issue":"5","key":"12557_CR18","first-page":"7","volume":"81","author":"Ministry of health of the People\u2019s","year":"2001","unstructured":"Ministry of health of the People\u2019s. Republic of China.Diagnostic criteria for nosocomial infections(proposed). Zhonghua Yi Xue Za Zhi. 2001;81(5):7.","journal-title":"Zhonghua Yi Xue Za Zhi"},{"issue":"3","key":"12557_CR19","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1007\/s00134-023-07295-2","volume":"50","author":"L Kreitmann","year":"2024","unstructured":"Kreitmann L, Helms J, Martin-Loeches I, Salluh J, Poulakou G, P\u00e8ne F, Nseir S. ICU-acquired infections in immunocompromised patients. Intensive Care Med. 2024;50(3):332\u201349.","journal-title":"Intensive Care Med"},{"issue":"1","key":"12557_CR20","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1186\/s13756-025-01590-x","volume":"14","author":"V Pitiriga","year":"2025","unstructured":"Pitiriga V, Campos E, Bakalis J, Sagris K, Georgiadis G, Saroglou G, Tsakris A. Effect of catheter dwell time on the risk of central line-associated bloodstream infections in central venous catheters and peripherally inserted central catheters. Antimicrob Resist Infect Control. 2025;14(1):70.","journal-title":"Antimicrob Resist Infect Control"},{"key":"12557_CR21","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1016\/j.jinf.2016.07.002","volume":"73","author":"MJ Satlin","year":"2016","unstructured":"Satlin MJ, Cohen N, Ma KC, et al. Bacteremia due to carbapenem-resistant Enterobacteriaceae in neutropenic patients with hematologic malignancies. J Infect. 2016;73:336\u201345.","journal-title":"J Infect"},{"issue":"6","key":"12557_CR22","doi-asserted-by":"publisher","first-page":"e101040","DOI":"10.1136\/bmjopen-2025-101040","volume":"15","author":"A Bergas","year":"2025","unstructured":"Bergas A, Lopez de Egea G, Albasanz-Puig A, Machado M, Vi\u00f1ado B, Est\u00e9vez-Prieto A, Maluquer C, Carro I, P\u00e9rez-Gonz\u00e1lez A, Regalado-Artamendi I, G\u00f3mez-Centuri\u00f3n IA, Laporte-Amarg\u00f3s J, Sastre-Escol\u00e0 E, Badia-Tejero AM, Garc\u00eda P, Larrosa N, Mu\u00f1oz P, Berbel D, Ardanuy C, Carratala J, Gudiol C. Effectiveness of the biofire filmarray for the rapid detection of bloodstream infection in haematological patients with febrile neutropenia (the ONFIRE study): study protocol of a prospective, multicentre observational study at three reference university hospitals in Spain. BMJ Open. 2025;15(6):e101040.","journal-title":"BMJ Open"},{"issue":"1","key":"12557_CR23","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1186\/s12866-023-03081-8","volume":"23","author":"M Roshani","year":"2023","unstructured":"Roshani M, Taheri M, Goodarzi A, Yosefimashouf R, Shokoohizadeh L. Evaluation of antibiotic resistance, toxin-antitoxin systems, virulence factors, biofilm-forming strength and genetic linkage of Escherichia coli strains isolated from bloodstream infections of leukemia patients. BMC Microbiol. 2023;23(1):327.","journal-title":"BMC Microbiol"},{"issue":"6","key":"12557_CR24","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1097\/MLR.0b013e3181dbd7ef","volume":"48","author":"SS Saleh","year":"2010","unstructured":"Saleh SS, Callan M, Therriault M, Landor N. The cost impact of hospital-acquired conditions among critical care patients. Med Care. 2010;48(6):518\u201326.","journal-title":"Med Care"},{"issue":"12","key":"12557_CR25","doi-asserted-by":"publisher","first-page":"1559","DOI":"10.1016\/j.cmi.2024.09.011","volume":"30","author":"A Loiodice","year":"2024","unstructured":"Loiodice A, Bailly S, Ruckly S, Buetti N, Barbier F, Staiquly Q, Tabah A, Timsit JF, EUROBACT-2 Study Group, the European Society of Intensive Care. Medicine (ESICM), the European society of clinical Microbiology, the infectious diseases (ESCMID) study group for infections in critically ill patients (ESGCIP) and the OUTCOMEREA Network. Effect of adequacy of empirical antibiotic therapy for hospital-acquired bloodstream infections on intensive care unit patient prognosis: a causal inference approach using data from the Eurobact2 study. Clin Microbiol Infect. 2024;30(12):1559\u201368.","journal-title":"Clin Microbiol Infect"},{"key":"12557_CR26","doi-asserted-by":"publisher","first-page":"9949633","DOI":"10.1155\/ijm\/9949633","volume":"2025","author":"F Gyilbagr","year":"2025","unstructured":"Gyilbagr F, Walana W, Buunaaim ADB, Vicar EK, Ankrah JNO, Frimpong EAB, Alhassan RB, Baako IS, Boakye AN, Akwetey SA, Karikari AB, Helegbe GK, Tabiri S. Bacterial isolates from orthopedic posttraumatic surgical infections in Northern ghana: ESbetaL detection and analysis of antimicrobial resistance trends. Int J Microbiol. 2025;2025:9949633.","journal-title":"Int J Microbiol"},{"key":"12557_CR27","doi-asserted-by":"publisher","first-page":"1503868","DOI":"10.3389\/fmed.2025.1503868","volume":"12","author":"G Zizzo","year":"2025","unstructured":"Zizzo G, Guazzardi G, Bompane D, Di Terlizzi F, Rotola G, Stefani I, Medugno M, Bucalo M. Mazzone A.Sepsis in internal medicine: blood culture-based subtypes, hospital outcomes, and predictive biomarkers. Front Med (Lausanne). 2025;12:1503868.","journal-title":"Front Med (Lausanne)"},{"key":"12557_CR28","doi-asserted-by":"publisher","first-page":"1616353","DOI":"10.3389\/fcimb.2025.1616353","volume":"15","author":"F Sivori","year":"2025","unstructured":"Sivori F, Francalancia M, Truglio M, Cavallo I, Pronesti C, Fabrizio G, Celesti I, Cazzani A, Furzi L, Pimpinelli F, Di Domenico EG. Meropenem\/vaborbactam activity against carbapenem-resistant Klebsiella pneumoniae from catheter-related bloodstream infections. Front Cell Infect Microbiol. 2025;15:1616353.","journal-title":"Front Cell Infect Microbiol"},{"key":"12557_CR29","doi-asserted-by":"crossref","unstructured":"Tozluyurt A. The effectiveness of aztreonam, aztreonam-avibactam, cefiderocol on blaNDM-producing Escherichia coli isolates. Mol Genet Microbiol Virol. 2024;39(2).","DOI":"10.3103\/S0891416824700198"},{"issue":"6","key":"12557_CR30","doi-asserted-by":"publisher","first-page":"1031","DOI":"10.1093\/cid\/ciac004","volume":"75","author":"PB Mazi","year":"2022","unstructured":"Mazi PB, Olsen MA, Stwalley D, Rauseo AM, Ayres C, Powderly WG, Spec A. Attributable mortality of Candida bloodstream infections in the modern era: A propensity score analysis. Clin Infect Dis. 2022;75(6):1031\u20136.","journal-title":"Clin Infect Dis"},{"issue":"9","key":"12557_CR31","doi-asserted-by":"publisher","first-page":"e0075124","DOI":"10.1128\/aac.00751-24","volume":"68","author":"MR Jacobs","year":"2024","unstructured":"Jacobs MR, Abdelhamed AM, Good CE, Mack AR, Bethel CR, Marshall S, Hujer AM, Hujer KM, Patel R, van Duin D, Fowler VG, Rhoads DD, Six DA, Moeck G, Uehara T, Papp-Wallace KM, Bonomo RA. ARGONAUT-III and -V: susceptibility of carbapenem-resistant Klebsiella pneumoniae and multidrug-resistant Pseudomonas aeruginosa to the bicyclic boronate \u03b2-lactamase inhibitor Taniborbactam combined with cefepime. Antimicrob Agents Chemother. 2024;68(9):e0075124.","journal-title":"Antimicrob Agents Chemother"},{"key":"12557_CR32","doi-asserted-by":"crossref","unstructured":"Tozluyurt A. Molecular typing of reduced susceptibility of Acinetobacter calcoaceticus\u2013baumannii complex to chlorhexidine in Turkey by pulsed-field gel electrophoresis. J Med Microbiol. 2024;73(8).","DOI":"10.1099\/jmm.0.001882"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12879-026-12557-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-026-12557-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-026-12557-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,11]],"date-time":"2026-02-11T01:04:05Z","timestamp":1770771845000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12879-026-12557-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,16]]},"references-count":32,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["12557"],"URL":"https:\/\/doi.org\/10.1186\/s12879-026-12557-7","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,16]]},"assertion":[{"value":"2 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The research protocol was reviewed and approved by the Ethics Committee of the Fifth Affiliated Hospital of Sun Yat-sen University (Approval number: No. 2025K250-1). This study strictly adheres to the ethical principles of the Declaration of Helsinki (World Medical Association, 2013) and relevant regulatory guidelines.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"310"}}